middle.news
Tryptamine Therapeutics Launches World-First Trial for Binge Eating Disorder
9:42am on Monday 23rd of June, 2025 AEST
•
Healthcare
Read Story
Tryptamine Therapeutics Launches World-First Trial for Binge Eating Disorder
9:42am on Monday 23rd of June, 2025 AEST
Key Points
Ethics approval granted for TRP-8803 trial in Binge Eating Disorder
Open-label study to dose 12 patients in two cohorts with two infusions 14 days apart
Patient recruitment underway; first dosing anticipated in Q3 2025
Trial explores safety, efficacy, and dosing flexibility alongside psychotherapy
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TYP
OPEN ARTICLE